viviant's blog

Drug development is a balancing act between ensuring that the drug is suitable for the target and that the drug can penetrate the cell membrane to reach the target. Typically, research into drugs that can cross cell membranes has focused on small, rigid molecules with nonpolar chemical structures. However, new therapeutic strategies break traditional drug design rules by using larger, flexibly linked chemical entities.

Profacgen, a protein service provider that enabling access to the latest tools, techniques, and expertise, recently enhanced its CLIP-Seq service which can map the RNA-binding landscape of interacting proteins or RNA modification sites over a genome-wide scale.